ESR1 and breast cancer: In this study we have used SSM2 and SSM3 ERα+/PR+ murine cell lines derived from spontaneous breast carcinomas in mice lacking STAT1, a transcription factor associated with tumor progression in ERα+ breast cancer patients [14].